Don’t Let Delays Hinder Progress: Uncover Hidden Insights to Optimize Your Oncology Trials with eCOA

Are your oncology trials bogged down by slow start-up times and lengthy protocol amendments? While all clinical trials have their complexities, oncology trials present unique challenges: diverse cancer types, intricate treatment plans, and long patient follow-up periods. These factors can significantly impact timelines and efficiency.

Here’s where eCOA steps in.

Electronic Clinical Outcome Assessment (eCOA) is a powerful technology that streamlines data collection, improves data quality, and enhances patient experience. But how exactly can eCOA benefit your oncology trials?

Our new report reveals:

Stop Wasting Time: Up to 80% of trials miss deadlines! YPrime tackles this head-on with a 25% faster startup process.

Effortless Amendments: Say goodbye to cumbersome protocol amendment implementations. Our platform facilitates swift and easy amendments.

Patient-Centric Approach: Enhance engagement and enrollment with user-friendly eCOA and streamlined eConsent features.

Real-World Results: See how YPrime empowers research.

With YPrime’s eCOA, you can stay ahead. Download your free copy of the report and unlock secrets to faster, more efficient oncology research!

Authors:

Drew Bustos, Chief Marketing Officer, YPrime
Donna Mongiello, SVP, eCOA Strategy, YPrime

Don’t Let Delays Hinder Progress: Uncover Hidden Insights to Optimize Your Oncology Trials with eCOA

Don’t Let Delays Hinder Progress: Uncover Hidden Insights to Optimize Your Oncology Trials with eCOs

Are your oncology trials bogged down by slow start-up times and lengthy protocol amendments? While all clinical trials have their complexities, oncology trials present unique challenges: diverse cancer types, intricate treatment plans, and long patient follow-up periods. These factors can significantly impact timelines and efficiency. Download your free copy of the report and unlock secrets to faster, more efficient oncology research!

Decreasing the Burden of
Oncology Clinical Trials with eCOA
A survey report revealing the need for flexible
technology that aids clinicians, patients and sponsors

Our new report reveals:

Finding and keeping patients engaged in trials remains a significant concern, which is no surprise given the 30% clinical trial dropout rate

Timelines and delays are pervasive, highlighting the pressure to meet goals and accelerate time-to-market

Managing the increasing complexity of study designs and protocol amendments is crucial in the dynamic landscape of oncology research

Timely implementation and integration with other eClinical technologies are essential for the overall success of the trial and staying within budget

Authors

Donna Mongiello, RN, BSN
SVP, eCOA Strategy,
YPrime

Drew Bustos
Chief Marketing Officer, YPrime